The Herpes Infection Treatment market size is USD 2.5 Bn in 2026.
The Herpes Infection Treatment market is projected to grow at a CAGR of 7% by 2033.
The Herpes Infection Treatment market growth drivers include rising herpes prevalence, increasing awareness, and expanding R&D initiatives.
North America is a dominating region for Herpes Infection Treatment market.
GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Novartis AG, and AbbVie Inc. are some leading industry players in the Herpes Infection Treatment market.